Actively Recruiting

Age: 6Months - 20Years
All Genders
ID00345553

Biliary Atresia Study in Infants and Children (BASIC)

Led by Arbor Research Collaborative for Health · Updated on 2026-06-04

1265

Participants Needed

16

Research Sites

N/A

Total Duration

On this page

Sponsors

A

Arbor Research Collaborative for Health

Lead Sponsor

N

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying biliary atresia, a liver condition in infants and children, to better understand what causes it and how it progresses over time. This observational study aims to identify the genes involved in biliary atresia and to describe the natural history of older children who still have their native liver. The study is conducted by the Childhood Liver Disease Research Network funded by the National Institute of Diabetes & Digestive and Kidney Diseases. The study involves collecting clinical information, genetic material, and body fluid samples from participants once, usually at the start of the study. Participants include children and young adults aged over 6 months up to 20 years who have a confirmed diagnosis of biliary atresia and still have their native liver. Researchers will follow these participants yearly to gather observational data about disease progression and quality of life. Participants will be asked to attend yearly follow-up visits where observational information will be collected, including health status and growth measurements. The primary measurement is to identify genetic factors linked to biliary atresia, while secondary outcomes include understanding disease progression and quality of life over time. The study tracks important health events, growth, and nutritional status to help predict outcomes. Participation may last several years, with annual visits to monitor the condition and collect data.

CONDITIONS

Brief Title

Biliary Atresia Study in Infants and Children

Who Can Participate

Age: 6Months - 20Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must have a confirmed diagnosis of biliary atresia based on medical records including biopsy, radiology, and surgery reports.
  • Participants must be older than 6 months and up to 20 years of age.
  • Participants must still have their native liver (no liver transplant).
  • Parent, guardian, or participant (if 18 or older) must be willing to provide informed consent and assent when appropriate.
Not Eligible

You will not qualify if you...

  • Currently participating in the ChiLDReN study PROBE.
  • Unable to confirm the original diagnosis of biliary atresia.
  • Unable or unwilling to participate in all scheduled study visits.
  • History of liver transplantation.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surveillance

Duration - Up to 7 years

Participants who have biliary atresia and their native liver are observed to collect clinical information, genetic material, and body fluid samples to study disease progression and related factors.

Annual visits

Trial Site Locations

Total: 16 locations

1

Children's Hospital of Los Angeles

Los Angeles, California, United States, 90027

Actively Recruiting

2

University of California at San Francisco

San Francisco, California, United States, 94143

Completed

3

Children's Hospital Colorado

Aurora, Colorado, United States, 80045

Actively Recruiting

4

Children's Healthcare of Atlanta - Emory University

Atlanta, Georgia, United States, 30322

Actively Recruiting

5

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States, 60614

Actively Recruiting

6

Riley Children's Hospital

Indianapolis, Indiana, United States, 46202

Completed

7

Johns Hopkins School of Medicine

Baltimore, Maryland, United States, 21287

Completed

8

Washington University School of Medicine

St Louis, Missouri, United States, 63110

Completed

9

Mount Sinai Medical Center

New York, New York, United States, 10029

Completed

10

Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229

Actively Recruiting

11

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

12

UPMC Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15224

Completed

13

Texas Children's Hospital (Baylor College of Medicine)

Houston, Texas, United States, 77030

Actively Recruiting

14

University of Utah

Salt Lake City, Utah, United States, 84113

Actively Recruiting

15

Seattle Children's Hospital

Seattle, Washington, United States, 98105

Actively Recruiting

16

Hospital for Sick Children

Toronto, Ontario, Canada, M5G 1X8

Completed

Loading map...

Research Team

M

Melissa Sexton, BBA, CCRP

M

Melissa Sexton, BBA

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Childhood Liver Disease Research Network (ChiLDReN): A Prosp...

Biliary Atresia

Actively Recruiting

16 locations

BILACO Trial: Biliary Atresia - a Severe Complex Congenital ...

Biliary Atresia

Actively Recruiting

1 location

Evaluation of the Use of Granulocyte Colony Stimulating Fact...

Granulocyte Colony-stimulating Factor

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Medical status of 219 children with biliary atresia surviving long-term with their native livers: results from a North American multicenter consortium.

Vicky Lee Ng, Barbara H Haber, John C Magee...

https://pubmed.ncbi.nlm.nih.gov/25015575